Boston Trust Walden Corp Laboratory Corp Of America Holdings Transaction History

Boston Trust Walden Corp

$14.1 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	BUY	$209.01 - $232.56 $1.73 Million - $1.92 Million	8,271 Added 35.87%	31,332 $6.84 Million
Q4 2023 Jan 24, 2024	SELL	$197.69 - $227.29 $16,210 - $18,637	-82 Reduced 0.35%	23,061 $5.24 Million
Q3 2023 Oct 18, 2023	BUY	$201.05 - $221.7 $31,765 - $35,028	158 Added 0.69%	23,143 $4.65 Million
Q2 2023 Jul 24, 2023	BUY	$211.93 - $241.33 $161,066 - $183,410	760 Added 3.42%	22,985 $5.55 Million
Q1 2023 Apr 19, 2023	SELL	$213.32 - $257.83 $54,396 - $65,746	-255 Reduced 1.13%	22,225 $5.1 Million
Q4 2022 Jan 20, 2023	SELL	$203.72 - $248.97 $7,130 - $8,713	-35 Reduced 0.16%	22,480 $0
Q3 2022 Oct 19, 2022	BUY	$204.81 - $262.19 $36,865 - $47,194	180 Added 0.81%	22,515 $4.61 Million
Q2 2022 Jul 22, 2022	SELL	$213.86 - $277.87 $211,721 - $275,091	-990 Reduced 4.24%	22,335 $5.24 Million
Q1 2022 Apr 20, 2022	BUY	$259.82 - $298.18 $190,967 - $219,162	735 Added 3.25%	23,325 $6.15 Million
Q4 2021 Jan 21, 2022	SELL	$271.6 - $314.21 $217,280 - $251,367	-800 Reduced 3.42%	22,590 $7.1 Million
Q3 2021 Oct 25, 2021	BUY	$274.82 - $308.34 $23,359 - $26,208	85 Added 0.36%	23,390 $6.58 Million
Q2 2021 Jul 22, 2021	BUY	$251.87 - $278.14 $2.36 Million - $2.61 Million	9,380 Added 67.36%	23,305 $6.43 Million
Q1 2021 Apr 21, 2021	SELL	$204.88 - $255.03 $117,806 - $146,642	-575 Reduced 3.97%	13,925 $3.55 Million
Q4 2020 Jan 15, 2021	SELL	$186.91 - $214.42 $22,429 - $25,730	-120 Reduced 0.82%	14,500 $2.95 Million
Q3 2020 Oct 14, 2020	SELL	$167.03 - $201.3 $129,448 - $156,007	-775 Reduced 5.03%	14,620 $2.75 Million
Q2 2020 Jul 23, 2020	BUY	$113.31 - $182.44 $96,313 - $155,074	850 Added 5.84%	15,395 $2.56 Million
Q1 2020 Apr 21, 2020	SELL	$104.32 - $195.28 $2,608 - $4,882	-25 Reduced 0.17%	14,545 $1.84 Million
Q4 2019 Jan 10, 2020	BUY	$163.48 - $173.61 $613,050 - $651,037	3,750 Added 34.66%	14,570 $2.47 Million
Q3 2019 Oct 21, 2019	BUY	$159.77 - $178.1 $215,689 - $240,435	1,350 Added 14.26%	10,820 $1.82 Million
Q2 2019 Jul 25, 2019	BUY	$144.16 - $172.9 $21,624 - $25,935	150 Added 1.61%	9,470 $1.64 Million
Q1 2019 Apr 16, 2019	SELL	$123.7 - $156.3 $123,700 - $156,300	-1,000 Reduced 9.69%	9,320 $1.43 Million
Q4 2018 Jan 17, 2019	BUY	$120.82 - $174.09 $495,362 - $713,769	4,100 Added 65.92%	10,320 $1.3 Million
Q3 2018 Oct 23, 2018	SELL	$167.67 - $188.27 $41,917 - $47,067	-250 Reduced 3.86%	6,220 $1.08 Million
Q2 2018 Jul 25, 2018	SELL	$160.33 - $189.41 $317,453 - $375,031	-1,980 Reduced 23.43%	6,470 $1.16 Million
Q4 2017 Jan 29, 2018	SELL	$147.99 - $163.95 $2.02 Million - $2.24 Million	-13,655 Reduced 61.77%	8,450 $1.35 Million
Q3 2017 Oct 13, 2017	BUY	$149.47 - $160.56 $3.3 Million - $3.55 Million	22,105	22,105 $3.34 Million

Others Institutions Holding LH

# of Institutions

Shares Held

1.94M

Call Options Held

Put Options Held

View Full List

About LABORATORY CORP OF AMERICA HOLDINGS

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

More about LH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.

Account